Ecklonia Cava

Ecklonia cava is a species of brown algae (Phaeophyceae) native to the Western Pacific, rich in unique phlorotannins that exhibit potent antioxidant, anti-inflammatory, and neuroprotective properties exceeding those of many terrestrial polyphenols.

Overview

Ecklonia cava is a perennial brown alga found predominantly in the coastal waters of Korea and Japan, growing at depths of 2 to 25 meters. It has been used for centuries in East Asian cuisine and traditional medicine. The alga is distinguished by its exceptionally high concentration of phlorotannins—polyphenolic compounds unique to brown algae—which are formed by the polymerization of phloroglucinol units. Key bioactive phlorotannins include dieckol, 6,6'-bieckol, and phlorofucofuroeckol-A, which demonstrate antioxidant activity 10 to 100 times greater than terrestrial polyphenols such as catechins and resveratrol due to their multiple hydroxyl groups and unique dibenzodioxin linkages.

Research has identified multiple mechanisms of action for Ecklonia cava extracts. In cardiovascular health, phlorotannins inhibit angiotensin-converting enzyme (ACE) and reduce LDL oxidation. Neuroprotective effects include inhibition of acetylcholinesterase and beta-secretase (BACE1), with studies showing improved cognitive function in animal models of Alzheimer's disease. The extracts also modulate inflammatory pathways by suppressing NF-κB activation and reducing production of nitric oxide, TNF-α, and IL-6.

A standardized Ecklonia cava extract known as Seapolynol has been studied in multiple human clinical trials, demonstrating improvements in sleep quality, metabolic markers, and vascular function. In 2008, the FDA granted GRAS (Generally Recognized as Safe) status to a polyphenol-rich extract of Ecklonia cava, facilitating its use in dietary supplements and functional foods in the United States.

Mechanism of Action

"

Phlorotannin-Mediated Multi-Target Antioxidant Activity\n\nEcklonia cava is a brown alga (Phaeophyceae) uniquely rich in phlorotannins — oligomeric/polymeric phenolic compounds derived from phloroglucinol (1,3,5-trihydroxybenzene) units linked via aryl-ether or biaryl bonds. Key bioactive phlorotannins include dieckol, 6,6'-bieckol, phlorofucofuroeckol-A, and eckol. These compounds exhibit potent radical scavenging activity (IC50 values of 5–15 microM against DPPH, superoxide, and hydroxyl radicals) through donation of phenolic hydrogen atoms and chelation of pro-oxidant transition metals (Fe2+, Cu2+). Dieckol activates the Nrf2/Keap1/ARE antioxidant response pathway by modifying Keap1 cysteine residues, releasing Nrf2 for nuclear translocation and transcription of phase II enzymes including HO-1, NQO1, gamma-GCS, and SOD (PMID: 22155268).\n\n

ACE Inhibition and Cardiovascular Protection\n\nPhlorotannins from Ecklonia cava act as potent angiotensin-converting enzyme (ACE) inhibitors by chelating the zinc ion in the ACE active site and forming hydrogen bonds with catalytic residues (His353, His383, Glu384). Dieckol demonstrates an ACE IC50 of approximately 1.5 mM. This reduces conversion of angiotensin I to angiotensin II, decreasing AT1 receptor-mediated vasoconstriction, aldosterone secretion, and sympathetic nervous system activation. Additionally, phlorotannins stimulate endothelial nitric oxide synthase (eNOS) via PI3K/Akt phosphorylation at Ser1177, increasing nitric oxide (NO) bioavailability and promoting endothelium-dependent vasodilation (PMID: 19507263).\n\n

Anti-Adipogenic and Metabolic Effects\n\nDieckol and phlorofucofuroeckol-A inhibit adipocyte differentiation by suppressing the PPARgamma/C/EBPalpha transcriptional cascade in 3T3-L1 preadipocytes. These phlorotannins activate AMPK through CaMKKbeta-dependent phosphorylation at Thr172, which inhibits ACC and SREBP-1c, reducing de novo lipogenesis. In the gut, Ecklonia cava phlorotannins inhibit pancreatic lipase (IC50 ~12 microM for dieckol) and alpha-glucosidase (IC50 ~2 microM), reducing dietary fat absorption and postprandial glucose spikes. Clinical studies with 144 mg/day Seapolynol for 12 weeks demonstrated reductions in body fat, waist circumference, and LDL cholesterol (PMID: 22253484)."

Reconstitution Calculator

Reconstitution Calculator

Calculate your peptide dosing

Draw Volume
0.100mL
Syringe Units
10units
Concentration
2,500mcg/mL
Doses / Vial
20doses
Vial Total
5mg
Waste / Vial
0mcg
Syringe Cap.
100units · 1mL
How to reconstitute
Gather & prepare
1/6Gather & prepare

Set up a clean workspace with all supplies ready.

1.Wash hands thoroughly, put on disposable gloves
2.Your 5mg peptide vial (lyophilized powder)
3.Bacteriostatic water (you'll need 2mL)
4.A 3–5mL syringe with 21–25 gauge needle for reconstitution
5.Alcohol swabs (70% isopropyl)
Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Sterile water is only safe for single-use.
Supply Planner

7x / week for weeks

·
40%
2vials
28 doses20 days/vial12 leftover
Cost Breakdown
Vial price
$0.00per dose
$0.00 /week$0 /month
Store 2-8°C30 day shelf lifeSwirl gentlyFor research purposes only

Research

Reported Effects

Antioxidant Profile:: Highly regarded for its fat-soluble antioxidant properties and extended half-life compared to water-soluble alternatives. Synergistic Benefits:: Users find it works better as part of comprehensive stacks rather than standalone supplementation. Research-Practice Gap:: Strong preclinical evidence exists, but limited user reports suggest benefits may be subtle or require longer-term use. Metabolic Applications:: Research shows clear benefits for blood sugar and weight management, though user reports focus more on antioxidant use

  • Highly regarded for its fat-soluble antioxidant properties and extended half-life compared to water-soluble alternatives
  • Users find it works better as part of comprehensive stacks rather than standalone supplementation
  • Strong preclinical evidence exists, but limited user reports suggest benefits may be subtle or require longer-term use
  • Research shows clear benefits for blood sugar and weight management, though user reports focus more on antioxidant use

Safety Profile

Safety Profile: Ecklonia Cava

Common Side Effects

  • Mild gastrointestinal symptoms including bloating, gas, and loose stools
  • Fishy aftertaste or mild nausea, especially on an empty stomach
  • Occasional mild headache during the first week of supplementation
  • Skin flushing or mild allergic reactions in iodine-sensitive individuals
  • Mild drowsiness due to GABAergic and anxiolytic properties

Serious Adverse Effects

  • Thyroid dysfunction (hypo- or hyperthyroidism) due to high iodine content with chronic high-dose use
  • Severe allergic reactions in individuals with shellfish or marine algae allergies
  • Potential anticoagulant effects leading to bleeding complications in predisposed individuals
  • Rare hepatotoxicity with prolonged use of concentrated extracts
  • Hypotension in susceptible individuals or when combined with antihypertensives

Contraindications

  • Known allergy to brown algae, kelp, or other marine organisms
  • Pre-existing thyroid disorders (use only under medical supervision with iodine monitoring)
  • Active bleeding disorders or upcoming surgery (discontinue 2 weeks prior)
  • Severe hypotension or orthostatic hypotension
  • Pregnancy and breastfeeding (insufficient safety data)

Drug Interactions

  • Anticoagulants/Antiplatelets (warfarin, aspirin, clopidogrel): Phlorotannins may enhance anticoagulant effects; increased bleeding risk
  • Thyroid medications (levothyroxine): High iodine content may interfere with thyroid hormone regulation
  • Antihypertensives (ACE inhibitors, ARBs): Additive blood pressure-lowering effects; monitor for hypotension
  • Antidiabetic agents (metformin, insulin): May potentiate hypoglycemic effects via alpha-glucosidase inhibition
  • Immunosuppressants: Immunomodulatory properties may interfere with drug efficacy

Population-Specific Considerations

  • Elderly: Generally well tolerated; monitor thyroid function and blood pressure regularly
  • Pediatric: Not recommended due to lack of safety data in children
  • Thyroid patients: Iodine content (varies by extract) may worsen thyroid conditions; requires medical oversight
  • Pregnant/Lactating women: Avoid due to unknown effects on fetal development and iodine transfer to breast milk
  • Autoimmune conditions: Use cautiously due to immunomodulatory polyphenols; may exacerbate or alter immune responses

Pharmacokinetic Profile

Quick Start

Typical Dose
300mg appears common in user stacks for general antioxidant support

Safety Profile

Common Side Effects

  • Minimal Reports:: Very few side effects mentioned in user discussions
  • Safety Profile:: Clinical trials report no significant adverse events at studied doses
  • Antioxidant Concerns:: One user questioned whether combining multiple high-ORAC supplements might be excessive
  • Individual Variation:: Limited user data makes it difficult to assess common side effects beyond research findings

References (9)

  1. [2]
    Influence of Supplementation of Ecklonia cava Polyphenols on Learning, Memory, and Brain Fatty Acid Composition in Mice

    Mice supplemented with Ecklonia cava polyphenols showed improved spatial learning and memory retention, along with increased DHA levels in brain and retinal tissue.

  2. [3]
    Brown Alga Ecklonia cava polyphenol extract ameliorates hepatic lipogenesis, oxidative stress, and inflammation by activation of AMPK and SIRT1 in high-fat diet-induced obese mice

    Ecklonia cava supplementation reduced body weight, fat deposition, and insulin resistance in obese mice through AMPK and SIRT1 activation pathways.

  3. [4]
    Marine Polyphenol Phlorotannins as a Natural Sleep Aid for Treatment of Insomnia: A Review of Sedative-Hypnotic Effects and Mechanism of Action

    Phlorotannins from brown algae exert sedative-hypnotic effects via GABA-A receptor modulation, suggesting potential as natural sleep aids.

  4. [5]
    Effects of Ecklonia cava Extract on Neuronal Damage and Apoptosis in PC-12 Cells against Oxidative Stress

    Ecklonia cava extract protected neuronal cells from oxidative damage and apoptosis while reducing intracellular oxidative stress in vitro.

  5. [6]
    Dieckol, a major phlorotannin in Ecklonia cava, suppresses lipid accumulation in the adipocytes of high-fat diet-fed zebrafish and mice: Inhibition of early adipogenesis via cell-cycle arrest and AMPKα activation

    Dieckol from Ecklonia cava reduced body weight gain by 38% and fat accumulation in mice through inhibition of adipogenesis and AMPK activation.

  6. [7]
    Efficacy and safety of a dieckol-rich extract (AG-dieckol) of brown algae, Ecklonia cava, in pre-diabetic individuals: a double-blind, randomized, placebo-controlled clinical trial

    In pre-diabetic adults, 12 weeks of Ecklonia cava supplementation significantly reduced postprandial glucose levels with no adverse effects reported.

  7. [8]
    Protective Effect of Brown Alga Phlorotannins against Hyper-inflammatory Responses in Lipopolysaccharide-Induced Sepsis Models

    Ecklonia cava extract increased survival rates in septic mice and reduced inflammatory markers through inhibition of the NFκB pathway and HO-1 activation.

  8. [9]
    Effect of supplementation with Ecklonia cava polyphenol on endurance performance of college students

    College students supplemented with Ecklonia cava polyphenols showed improvements in endurance exercise performance.

  9. [1]
    Ecklonia cava Ameliorates Cognitive Impairment on Amyloid β-Induced Neurotoxicity by Modulating Oxidative Stress and Synaptic Function in Institute of Cancer Research (ICR) Mice

    Ecklonia cava improved cognitive function in mice with Alzheimer's-like conditions by reducing oxidative stress and supporting synaptic function in the brain.

Updated 2026-03-08Sources: peptidebay

On this page